ALDH18A1 and cancer: The similarity of Proteomap patterns between the GPRlow/TMEhigh subgroup and TIDE immunotherapy-responder subgroups might reveal a certain commonality in a determinative interplay between patients’ immune system and cancer cells, which further indicated the therapeutic predictive value of the GPR-TME classifier.